Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
about
The role of natalizumab in the treatment of multiple sclerosis: benefits and risks.Neuropathology of autonomic dysfunction in synucleinopathies.REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?Pure autonomic failure without alpha-synuclein pathology: an evolving understanding of a heterogeneous disease.Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis.
P2860
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@en
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@nl
type
label
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@en
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@nl
prefLabel
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@en
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@nl
P2093
P2860
P1433
P1476
Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
@en
P2093
Elizabeth A Coon
Mariana D Suarez
Paola Sandroni
Phillip A Low
Robert D Fealey
Sarah E Berini
Wolfgang Singer
P2860
P304
P356
10.1212/WNL.0000000000003737
P407
P577
2017-02-15T00:00:00Z